Nervous System

Patients with post-incident dementia were more likely to begin central nervous system medications and less likely to discontinue cardiometabolic and anticholinergic medications, reflecting missed deprescribing opportunities, according to researchers.

A Bay Area-based biopharmaceutical company has announced initiation of a phase 1 clinical trial for its oral, small molecule SARM1 inhibitor, NB-4746, to treat a wide range of conditions affecting the central, peripheral and ocular nervous systems.

I recently saw a 40-year-old woman who had undergone decompression with a C1 laminectomy for an emergent chiari malformation that was causing short-term memory problems, visual depletion, and speech and swallowing difficulties.

CHICAGO — Igor J. Koralnik, MD, discusses highlights from his presentation at the 2022 American Neurological Association’s annual meeting on long COVID and its effect on the nervous system.

The use of TNF inhibitors among patients with autoimmune disease may be associated with an increased risk for inflammatory central nervous system events, according to data published in JAMA Neurology.